PROBLEM: Emerging evidence suggests that metabolism influences immune cell signaling and immunoregulation. To examine the immunoregulatory role of glycolysis in pregnancy, we evaluated the properties of pyruvate kinase in leukocytes from non-pregnant women and those with normal pregnancy and pre-eclampsia. METHOD OF STUDY: We evaluated pyruvate kinase expression in lymphocytes and neutrophils from non-pregnant, pregnant, and pre-eclampsia patients using fluorescence microscopy and flow cytometry. Leukocyte pyruvate kinase activity and pyruvate concentrations were also evaluated. To study pyruvate's effect on signaling, we labeled Jurkat T cells with Ca(2+) dyes and measured cell responses in the presence of agents influencing intracellular pyruvate. RESULTS: The expression of pyruvate kinase is reduced in lymphocytes and neutrophils from normal pregnant women in comparison with those of non-pregnant women and pre-eclampsia patients. Similarly, the activity of pyruvate kinase and the intracellular pyruvate concentration are reduced in leukocytes of normal pregnant women in comparison with non-pregnant women and women with pre-eclampsia. Using Jurkat cells as a model of leukocyte signaling, we have shown that perturbations of intracellular pyruvate influence Ca(2+) signals. CONCLUSION: Normal pregnancy is characterized by reduced pyruvate kinase expression within lymphocytes and neutrophils. We speculate that reduced pyruvate kinase expression modifies immune cell responses due to reduced pyruvate concentrations.
PROBLEM: Emerging evidence suggests that metabolism influences immune cell signaling and immunoregulation. To examine the immunoregulatory role of glycolysis in pregnancy, we evaluated the properties of pyruvate kinase in leukocytes from non-pregnant women and those with normal pregnancy and pre-eclampsia. METHOD OF STUDY: We evaluated pyruvate kinase expression in lymphocytes and neutrophils from non-pregnant, pregnant, and pre-eclampsiapatients using fluorescence microscopy and flow cytometry. Leukocyte pyruvate kinase activity and pyruvate concentrations were also evaluated. To study pyruvate's effect on signaling, we labeled Jurkat T cells with Ca(2+) dyes and measured cell responses in the presence of agents influencing intracellular pyruvate. RESULTS: The expression of pyruvate kinase is reduced in lymphocytes and neutrophils from normal pregnant women in comparison with those of non-pregnant women and pre-eclampsiapatients. Similarly, the activity of pyruvate kinase and the intracellular pyruvate concentration are reduced in leukocytes of normal pregnant women in comparison with non-pregnant women and women with pre-eclampsia. Using Jurkat cells as a model of leukocyte signaling, we have shown that perturbations of intracellular pyruvate influence Ca(2+) signals. CONCLUSION: Normal pregnancy is characterized by reduced pyruvate kinase expression within lymphocytes and neutrophils. We speculate that reduced pyruvate kinase expression modifies immune cell responses due to reduced pyruvate concentrations.
Authors: R Oehler; G Weingartmann; N Manhart; U Salzer; M Meissner; W Schlegel; A Spittler; M Bergmann; D Kandioler; C Oismüller; H M Struse; E Roth Journal: Blood Date: 2000-02-01 Impact factor: 22.113
Authors: M T Gervasi; T Chaiworapongsa; P Pacora; N Naccasha; B H Yoon; E Maymon; R Romero Journal: Am J Obstet Gynecol Date: 2001-10 Impact factor: 8.661
Authors: Amanda K Pearce; Kay Crimmins; Evelyne Groussac; Michael J E Hewlins; J Richard Dickinson; Jean Francois; Ian R Booth; Alistair J P Brown Journal: Microbiology (Reading) Date: 2001-02 Impact factor: 2.777
Authors: Sun Kwon Kim; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Pooja Mittal; Offer Erez; Edi Vaisbuch; Francesca Gotsch; Percy Pacora; Lami Yeo; Maria Teresa Gervasi; Ronald F Lamont; Bo Hyun Yoon; Sonia S Hassan Journal: J Perinat Med Date: 2009 Impact factor: 1.901
Authors: Koichi Araki; Alexandra P Turner; Virginia Oliva Shaffer; Shivaprakash Gangappa; Susanne A Keller; Martin F Bachmann; Christian P Larsen; Rafi Ahmed Journal: Nature Date: 2009-06-21 Impact factor: 49.962
Authors: N Jones; J Piasecka; A H Bryant; R H Jones; D O F Skibinski; Nigel J Francis; C A Thornton Journal: Clin Exp Immunol Date: 2015-07-24 Impact factor: 4.330
Authors: April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton Journal: Clin Exp Immunol Date: 2022-06-11 Impact factor: 5.732